Argenica Therapeutics (ASX:AGN) - Webinar Presentation

Company Presentations

by Finance News Network


Dr Liz Dallimore - CEO & Managing Director - Argenica Therapeutics Limited (ASX:AGN) is developing novel neuroprotective therapeutics to reduce brain damage after stroke.

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?